Research

When scientific curiosity paves the way for improved healthcare: Read more about promising studies and trials that lead to more effective drugs, procedures as well as medical guidelines.

Photo

News • Current insights and research priorities

Atrial fibrillation during sepsis: what clinicians know (and what they don't)

A new review brings together the current evidence on sepsis-associated atrial fibrillation (SAAF) – and maps the research needed to close the gaps.

Photo

News • Study on differing connectivity gradients

Alzheimer's: Researchers explore the dark side of the aging brain

Normal aging and Alzheimer’s disease reshape communication across the brain in distinct patterns. By differentiating these patterns, researchers are developing a new way for early detection.

Photo

News • Nature images and calming music

VR instead of medication? A new approach to high blood pressure in the ED

Patients who arrive in the emergency department with elevated blood pressure are extremely common. Instead of treating them with blood pressure medication, a new study tried a calming VR experience.

Photo

Article • San Antonio Breast Cancer Symposium (SABCS)

Young women and breast cancer: research in focus

At the San Antonio Breast Cancer Symposium (SABCS), three experts presented new approaches and study results for the treatment of breast cancer in young women.

Photo

News • Preventive transmission model

How C. diff spreads in a hospital oncology ward

Many cancer treatments leave their recipients immunocompromised and at greater risk of infection. A new transmission model aims to better prevent transmission in hospitals' oncology wards.

Photo

News • Benefits of reduced sugar consumption

Skipping sweets could help protect the gut microbiome during antibiotic therapy

Could a patient's sweet tooth sabotage antibiotic treatment for blood cancer? A study suggests that eating less sugar could protect the microbiome during allogeneic hematopoietic cell transplant.

Photo

News • RxFINE-Low trial

Evaluating chemotherapy benefit in high-risk early-stage breast cancer

Can patients with high anatomic risk but low genomic risk for early-stage ER+/HER2- breast cancer do similarly well without chemotherapy? A new trial aims to evaluate the benefits for this subgroup.

3063 show more articles
Subscribe to Newsletter